EVENTS:   The Roaring 2020s or a Rerun of the 1970s? - Edward Yardeni/Yardeni Research - 24 Mar 26   Best Equity Short Ideas Conference Call 13 - Thomas Chanos/Badger Consultants & Dr. Aaron Fletcher/Bios Research & Jonathan Telgener/Channel Dynamics & Ed Steele/Iron Blue Financials & John Zolidis/Quo Vadis Capital & Mark Hiley/The Analyst - 26 Mar 26     ROADSHOWS: Chinese Equity Ideas & Channel Checks Across 50 sub-sectors - Don Ma /Horizon Insights   •   London   23 - 27 Mar 26       Long Short European Equity Research - Harry Grist /The Analyst   •   New York   26 Mar 26       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   27 - 27 Mar 26      
Filters

Fortnightly Publication Highlighting Latest Insights From IRF Providers

Company Research

Novanta (NOVT)

Industrials

Costigan Reports

Having successfully identified the transformation at NOVT (turned bullish June 2017 at $36; current share price $176), Bob Costigan believes the company is poised to enter a rapid growth phase as it takes advantage of the global shift to mobile robotics. He projects revenue CAGR of 15%+ (10% organic), OCF CAGR of 30%+ and EPS CAGR of 30%+ (2022-24). NOVT has a history of innovation and Bob expects investment in R&D to increase to 9% of sales in each of the next three years. 1-yr TP $220; 3-yr TP $320 (90% upside).

Edition: 126

- 07 January, 2022